Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.

Colak D, Chishti MA, Al-Bakheet AB, Al-Qahtani A, Shoukri MM, Goyns MH, Ozand PT, Quackenbush J, Park BH, Kaya N.

Mol Cancer. 2010 Jun 12;9:146. doi: 10.1186/1476-4598-9-146.

PMID:
20540791
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.

Schröder PC, Segura V, Riezu JI, Sangro B, Mato JM, Prieto J, Santamaría E, Corrales FJ.

Funct Integr Genomics. 2011 Sep;11(3):419-29. doi: 10.1007/s10142-011-0230-7. Epub 2011 May 12.

PMID:
21562899
[PubMed - indexed for MEDLINE]
3.

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.

Colak D, Nofal A, Albakheet A, Nirmal M, Jeprel H, Eldali A, Al-Tweigeri T, Tulbah A, Ajarim D, Malik OA, Inan MS, Kaya N, Park BH, Bin Amer SM.

PLoS One. 2013 May 21;8(5):e63204. doi: 10.1371/journal.pone.0063204. Print 2013.

PMID:
23704896
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Comparative genomic classification of human hepatocellular carcinoma].

Kaposi-Novák P.

Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9. Hungarian.

PMID:
19318328
[PubMed - indexed for MEDLINE]
Free Article
5.

An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.

Frau M, Simile MM, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo CF, Massarelli G, Solinas G, Feo F, Lee JS, Pascale RM.

Cell Oncol (Dordr). 2012 Jun;35(3):163-73. doi: 10.1007/s13402-011-0067-z. Epub 2012 Mar 21.

PMID:
22434528
[PubMed - indexed for MEDLINE]
6.

Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.

Ip WK, Lai PB, Wong NL, Sy SM, Beheshti B, Squire JA, Wong N.

Cancer Lett. 2007 Jun 8;250(2):284-91. Epub 2006 Nov 28.

PMID:
17126992
[PubMed - indexed for MEDLINE]
7.

Induction of cell proliferation in old rat liver can reset certain gene expression levels characteristic of old liver to those associated with young liver.

Chishti MA, Kaya N, Binbakheet AB, Al-Mohanna F, Goyns MH, Colak D.

Age (Dordr). 2013 Jun;35(3):719-32. doi: 10.1007/s11357-012-9404-z. Epub 2012 Apr 4.

PMID:
22477361
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.

Coulouarn C, Factor VM, Conner EA, Thorgeirsson SS.

Carcinogenesis. 2011 Oct;32(10):1434-40. doi: 10.1093/carcin/bgr133. Epub 2011 Jul 18.

PMID:
21771728
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.

Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.

J Cancer Res Clin Oncol. 2003 Jan;129(1):43-51. Epub 2002 Dec 4.

PMID:
12618900
[PubMed - indexed for MEDLINE]
10.

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X.

Carcinogenesis. 2005 Dec;26(12):2050-7. Epub 2005 Jul 6.

PMID:
16000397
[PubMed - indexed for MEDLINE]
Free Article
11.

Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.

Tilton SC, Gerwick LG, Hendricks JD, Rosato CS, Corley-Smith G, Givan SA, Bailey GS, Bayne CJ, Williams DE.

Toxicol Sci. 2005 Dec;88(2):319-30. Epub 2005 Sep 1.

PMID:
16141433
[PubMed - indexed for MEDLINE]
Free Article
12.

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, Buonaguro L, Marincola FM, Wang E, Buonaguro FM.

J Transl Med. 2009 Oct 12;7:85. doi: 10.1186/1479-5876-7-85.

PMID:
19821982
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW.

Clin Cancer Res. 2007 Feb 15;13(4):1133-9.

PMID:
17317821
[PubMed - indexed for MEDLINE]
Free Article
14.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

PMID:
20388846
[PubMed - indexed for MEDLINE]
Free Article
15.

Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma.

Chen ZM, Crone KG, Watson MA, Pfeifer JD, Wang HL.

Am J Surg Pathol. 2005 Dec;29(12):1600-8.

PMID:
16327432
[PubMed - indexed for MEDLINE]
16.

Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling.

Fang H, Tong W, Perkins R, Shi L, Hong H, Cao X, Xie Q, Yim SH, Ward JM, Pitot HC, Dragan YP.

BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S6.

PMID:
16026603
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
[PubMed - indexed for MEDLINE]
18.

Expression profile reveals novel prognostic biomarkers in hepatocellular carcinoma.

Sun M, Wu G, Li Y, Fu X, Huang Y, Tang R, Guo Y, Qiu M, Mao Y, Zhao F, Li L, Huang S, Zhao X, Xie Y.

Front Biosci (Elite Ed). 2010 Jun 1;2:829-40.

PMID:
20515756
[PubMed - indexed for MEDLINE]
19.

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.

J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.

PMID:
21419759
[PubMed - indexed for MEDLINE]
20.

The HOX gene network in hepatocellular carcinoma.

Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, D' Armiento M, Roncalli M, Sansano S, Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J, Terracciano L.

Int J Cancer. 2011 Dec 1;129(11):2577-87. doi: 10.1002/ijc.25941. Epub 2011 May 30.

PMID:
21626505
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk